HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria

被引:0
|
作者
Qi Sun
Qi Li
Fuping Gao
Hongyan Wu
Yao Fu
Jun Yang
Xiangshan Fan
Xiaobin Cui
Xiaohong Pu
机构
[1] Nanjing Drum Tower Hospital,Department of Pathology
[2] The Affiliated Hospital of Nanjing University Medical School,Center for Digestive Medicine
[3] Nanjing Drum Tower Hospital,Department of Pathology
[4] The Affiliated Hospital of Nanjing University Medical School,undefined
[5] Gaochun People’s Hospital,undefined
关键词
Colorectal carcinomas; HER2; Fluorescence in situ hybridization; Immunohistochemistry;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:579 / 592
页数:13
相关论文
共 50 条
  • [21] Concordance of HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Using Tissue Microarray in Breast Cancer
    Furrer, Daniela
    Jacob, Simon
    Caron, Chantal
    Sanschagrin, Francois
    Provencher, Louise
    Diorio, Caroline
    ANTICANCER RESEARCH, 2017, 37 (06) : 3323 - 3329
  • [22] HER 2 protein overexpression and gene amplification in breast cancer:: A comparison of immunohistochemistry and fluorescent and chromogenic in situ hybridization
    Sáez, A
    Andreu, F
    Fernández, S
    Seguí, M
    Rey, M
    LABORATORY INVESTIGATION, 2005, 85 : 49A - 49A
  • [23] HER 2 protein overexpression and gene amplification in breast cancer:: A comparison of immunohistochemistry and fluorescent and chromogenic in situ hybridization
    Sáez, A
    Andreu, FJ
    Fernández, S
    Seguí, MA
    Rey, M
    MODERN PATHOLOGY, 2005, 18 : 49A - 49A
  • [24] Determination of the HER2 amplification status by in situ fluorescent hybridization and concordance with immunohistochemistry for breast cancer samples in Colombia
    Plata, Adriana
    Torres, Maria Mercedes
    Lopez, Rocio
    Andrade, Rafael E.
    COLOMBIA MEDICA, 2013, 44 (02): : 108 - 114
  • [25] Comparison of fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH) for assessment of HER2 gene amplification in breast cancer
    Bhargava, R
    Lal, P
    Salazar, PA
    Chen, B
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2004, 6 (02): : 151 - 151
  • [26] HER2 testing in patients with breast cancer: Poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization
    Perez, EA
    Roche, PC
    Jenkins, RB
    Reynolds, CA
    Halling, KC
    Ingle, JN
    Wold, LE
    MAYO CLINIC PROCEEDINGS, 2002, 77 (02) : 148 - 154
  • [27] Comparison of Fluorescence in situ Hybridization and Immunohistochemistry for Assessment of HER-2 Status in Breast Cancer Patients
    王琳
    王晓蓓
    聂秀
    马玲
    Current Medical Science, 2009, 29 (03) : 354 - 358
  • [28] Discrepancy Between HER2 Immunohistochemistry and Fluorescence In Situ Hybridization in Esophageal and Gastric Adenocarcinoma
    Huh, Won Jae
    Sanders, Melinda
    Charoenpitakchai, Mongkon
    Salaria, Safia
    Washington, Mary
    Shi, Chanjuan
    LABORATORY INVESTIGATION, 2015, 95 : 165A - 166A
  • [29] Comparison of fluorescence in situ hybridization and immunohistochemistry for assessment of HER-2 status in breast cancer patients
    Lin Wang
    Xiaobei Wang
    Xiu Nie
    Ling Ma
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2009, 29 : 354 - 358
  • [30] Comparison of Fluorescence in situ Hybridization and Immunohistochemistry for Assessment of HER-2 Status in Breast Cancer Patients
    Wang, Lin
    Wang, Xiaobei
    Nie, Xiu
    Ma, Ling
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2009, 29 (03) : 354 - 358